March 23, 2010
Almost all — some 94 percent — of the researchers who published favorable medical journal studies and commentaries on the controversial diabetes drug rosiglitazone had financial ties with pharmaceutical companies that manufacture it or similar drugs, a Mayo Clinic study has found… “One-fourth of the folks who were having an opinion on this debate […]
March 15, 2010
Conflict-of-Interest Policies: A Detailed Look
Earlier this year, Harvard’s Partners Healthcare put a cap on payments its physicians can receive for serving on corporate boards at $5,000 a day… Because of these committees, most universities know the extent of their employees’ involvement in industry relationships, said Marianne Hockema, MA, an administrator in the Office of Conflict of Interest Review […]